The MISTRAL study, involving 290 patients with advanced pancreatic cancer, has investigated whether treatment with mistletoe extract (ME) in addition to standard treatment could help patients live longer. The result is that the treatment did not make any difference compared to placebo in how long the patients lived. The study is published in Deutsches Ärzteblatt international.
Trial shows mistletoe extract does not increase survival in advanced pancreatic cancer
The MISTRAL study, involving 290 patients with advanced pancreatic cancer, has investigated whether treatment with mistletoe extract (ME) in addition to standard treatment could help patients live longer. The result is that the treatment did not make any difference compared to placebo in how long the patients lived. The study is published in Deutsches Ärzteblatt international.